A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.

Παρόμοια τεκμήρια

• Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.
  ανά: Chan, P, κ.ά.
  Έκδοση: (2008)
• Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
  ανά: Dumoulin, M, κ.ά.
  Έκδοση: (2005)
• Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme.
  ανά: Canet, D, κ.ά.
  Έκδοση: (2002)
• A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation.
  ανά: De Genst, E, κ.ά.
  Έκδοση: (2013)
• Investigation of non-covalent interactions of amyloidogenic human lysozyme variants and camelid antibodies
  ανά: Caddy, G, κ.ά.
  Έκδοση: (2002)